Innovative Approach Boosts Immunotherapy Effectiveness in Bladder Cancer and Other Tumors
A novel combination of BCG therapy and fungal-derived β-glucan has shown to dramatically enhance immune response and tumor eradication in bladder cancer, opening new avenues for effective cancer immunotherapies.
A groundbreaking discovery has paved the way for enhancing immunotherapy treatments for bladder cancer and potentially other solid tumors. The study, led by Senior Scientist Maziar Divangahi at McGill University, reveals that combining Bacillus Calmette-Guérin (BCG) therapy—used for non-muscle invasive bladder cancer—with a natural fungal molecule called β-glucan significantly improves treatment outcomes. BCG therapy, introduced over 50 years ago, involves instilling a weakened tuberculosis bacteria strain into the bladder to stimulate an immune response against cancer cells. Despite being the standard treatment, it faces limitations, such as high recurrence rates, side effects, and limited efficacy in some patients.
The innovative approach discovered by Dr. Leonardo Jurado and colleagues shows that β-glucan reinforces the body's innate immune response. It trains neutrophils, a type of immune cell derived from stem cells in the bone marrow, to aggressively combat tumor cells. This dual therapy not only enhances immune cell activation but also results in complete tumor eradication and 100% survival in preclinical mouse models of bladder cancer. Remarkably, this success suggests the potential for longer-lasting and more effective treatments, reducing recurrence and side effects.
Furthermore, this strategy might be applicable beyond bladder cancer, showing promise against other cancers like melanoma. Professor Divangahi emphasizes that training innate immune cells could revolutionize next-generation cancer immunotherapies. The research team is now preparing for clinical trials to evaluate the safety and efficacy of this combined treatment in patients.
This discovery highlights a significant step forward in personalized cancer treatment, leveraging natural immune mechanisms to achieve durable responses. It underscores Canada's leadership in cancer immunotherapy innovation and could have a profound impact globally in cancer care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Detection of Aging Signals in Liver Tissue Offers Potential for Disease Prediction
Innovative single-cell analysis technology enables early detection of tissue aging signals in the liver, improving disease prediction and personalized treatment strategies.
T Cells and Testosterone: Implications for Prostate Cancer Treatment
New research reveals that T cells can sense testosterone, unlocking new potential for personalized prostate cancer therapies by understanding immune hormone interactions.
New Insights into Molecular Mechanisms Could Lead to Causal Therapies for Epilepsy
Recent research from Vienna uncovers a molecular pathway linked to epilepsy development, paving the way for targeted therapies that address the disease's root causes rather than just managing symptoms.
Understanding How Breast Tissue Density Influences Breast Cancer Risk
Breast tissue density significantly impacts breast cancer risk and detection. Women with dense breasts face higher risks and challenges in early diagnosis, emphasizing the importance of awareness and personalized screening.